Annexin A5 protein expression is associated with the histological differentiation of uterine cervical squamous cell carcinoma in patients with an increased serum concentration

Molecular Medicine Reports

Volumn 6, Issue 6, 2012, Pages 1249-1254

  Li, Xin ^a   Chen, Long ^a   Liang, Xiu Jun ^a   Gao, Yu Feng ^a   Wang, Xiao Jie ^a   Xu, Qian ^a   Yan, Yong ^a   Gao, Fu Lu ^b  

^a CHENGDE MEDICAL COLLEGE   (China)

^b HEBEI NORMAL UNIVERSITY   (China)

Author keywords

Annexin A5; Expression; Histological differentiation; Serum concentration; Uterine cervical squamous cell carcinoma

Indexed keywords

LIPOCORTIN 5;

ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIUM DYSPLASIA; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MOLECULAR DYNAMICS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DIFFERENTIATION; TUMOR DIFFERENTIATION; UPREGULATION; UTERINE CERVIX CARCINOMA; WESTERN BLOTTING;

ANNEXIN A5; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM GRADING; PROGNOSIS; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS;

EID: 84868590531     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1078     Document Type: Article

References (24)

1. Greenlee RT, Hill-Harmon MB, Murray T and Thun M: Cancer statistics. CA Cancer J Clin 51: 15-36, 2001.
2. Mortimer JC, Laohavisit A, Macpherson N, Webb A, Brownlee C, Battey NH and Davies JM: Annexins: multifunctional components of growth and adaptation. J Exp Bot 59: 533-544, 2008. (Pubitemid 351640742)
3. 2+ handling in the heart. Cardiovasc Res 65: 793-802, 2005.
4. Russo-Marie F: Annexin V and phospholipid metabolism. Clin Chem Lab Med 37: 287-291, 1999.
5. Gerke V and Moss SE: Annexins: from structure to function. Physiol Rev 82: 331-371, 2002. (Pubitemid 34654456)
6. Rand JH, Wu XX, Quinn AS and Taatjes DJ: The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis. Lupus 19: 460-469, 2010.
7. Kenis H, van Genderen H, Deckers NM, Lux PA, Hofstra L, Narula J and Reutelingsperger CP: Annexin A5 inhibits engulfment through internalization of PS-expressing cell membrane patches. Exp Cell Res 312: 719-726, 2006.
8. Kim DM, Noh HB, Park DS, Ryu SH, Koo JS and Shim YB: Immunosensors for detection of Annexin II and MUC5AC for early diagnosis of lung cancer. Biosens Bioelectron 25: 456-462, 2009.
9. Califano J, van der Riet P, Westra W, et al: Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56: 2488-2492,1996. (Pubitemid 26170679)
10. Hattori T, Hoffman T and Hirata F: Differentiation of a histiocytic lymphoma cell line by lipomodulin, a phospholipase inhibitory protein. Biochem Biophys Res Commun 111: 551-559, 1983. (Pubitemid 13119240)
11. Duncan R, Carpenter B, Main LC, Telfer C and Murray GI: Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer 98: 426-433, 2008. (Pubitemid 351161239)
12. Kim JK, Kim PJ, Jung KH, et al: Decreased expression of annexin A10 in gastric cancer and its overexpression in tumor cell growth suppression. Oncol Rep 24: 607-612, 2010.
13. Zhao P, Zhang W, Tang J, et al: Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147. Cancer Sci 101: 387-395, 2010.
14. Liu YF, Xiao ZQ, Li MX, et al: Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma. J Pathol 217: 54-64, 2009.
15. Zhang Z, Huang L, Zhao W and Rigas B: Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Res 70: 2379-2388, 2010.
16. Torosyan Y, Dobi A, Glasman M, et al: Role of multi-hnRNP nuclear complex in regulation of tumor suppressor ANXA7 in prostate cancer cells. Oncogene 29: 2457-2466, 2010.
17. Mulla A, Christian HC, Solito E, Mendoza N, Morris JF and Buckingham JC: Expression, subcellular localization and phosphorylation status of annexins 1 and 5 in human pituitary adenomas and a growth hormone-secreting carcinoma. Clin Endocrinol (Oxford) 60: 107-119, 2004. (Pubitemid 38183506)
18. Dooley TP, Reddy SP, Wilborn TW and Davis RL: Biomarkers of human cutaneous squamous cell carcinoma from tissues and cell lines identified by DNA microarrays and qRT-PCR. Biochem Biophys Res Commun 306: 1026-1036, 2003. (Pubitemid 36776234)
19. Wehder L, Arndt S, Murzik U, Bosserhoff AK, Kob R, von Eggeling F and Melle C: Annexin A5 is involved in migration and invasion of oral carcinoma. Cell Cycle 8: 1552-1558, 2009.
20. Karube A, Shidara Y, Hayasaka K, Maki M and Tanaka T: Suppression of calphobidin I (CPB I) production in carcinoma of uterine cervix and endometrium. Gynecol Oncol 58: 295-300, 1995.
21. Bae SM, Min HJ, Ding GH, et al: Protein expression profile using two-dimensional gel analysis in squamous cervical cancer patients. Cancer Res Treat 38: 99-107, 2006.
22. Guzmán-Aránguez A, Olmo N, Turnay J, Lecona E, Pérez-Ramos P, López de Silanes I and Lizarbe MA: Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5. J Cell Bioche 94: 178-193, 2005. (Pubitemid 41420335)
23. Xue G, Hao LQ, Ding FX, et al: Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas. J Clin Gastroenterol 43: 831-837, 2009.
24. Lomnytska MI, Becker S, Hellman K, et al: Diagnostic protein marker patterns in squamous cervical cancer. Proteomics Clin Appl 4: 17-31, 2010.